Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
IN |
|
Maps SpA
MIL:MAPS
|
IT |
|
C
|
Centrais Eletricas Brasileiras SA
NYSE:EBR
|
BR |
|
W
|
Waste Management Inc
F:UWS
|
US |
|
Agree Realty Corp
NYSE:ADC
|
US |
|
Regional Management Corp
NYSE:RM
|
US |
|
I
|
Investment and Industrial Development Joint Stock Corp
VN:BCM
|
VN |
|
Clearone Inc
NASDAQ:CLRO
|
US |
|
Hydrogenpro ASA
OSE:HYPRO
|
NO |
Wall St Price Targets
SUNPHARMA Price Targets Summary
Sun Pharmaceutical Industries Ltd
According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 048.79 INR with a low forecast of 1 666.5 INR and a high forecast of 2 835 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SUNPHARMA's stock price target?
Price Target
2 048.79
INR
According to Wall Street analysts, the average 1-year price target for SUNPHARMA is 2 048.79 INR with a low forecast of 1 666.5 INR and a high forecast of 2 835 INR.
What is the Revenue forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 4 years is 11%.
What is the Operating Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 4 years is 13%.
What is the Net Income forecast for Sun Pharmaceutical Industries Ltd?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 6 years is 14%.
